High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.4M
$2,353,964
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $83,185 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2026-03-16 | $16,493 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $41,529 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2026-03-16 | $2,433 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2026-01-09 | $2,433 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2026-01-09 | $28,881 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2026-01-09 | $132,082 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2026-01-09 | $555,918 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2025-10-09 | $21,959 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2025-10-09 | $259,673 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2025-09-29 | $23,214 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2025-09-29 | $499,868 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2025-09-19 | $6,505 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2025-09-19 | $139,350 | S | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
Other
|
2025-09-18 | $34,784 | M | Form 4 |
| CGON |
CG Oncology, Inc.
|
Director
10b5-1 Sell
|
2025-09-18 | $745,559 | S | Form 4 |